This inventor holds 2 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Mesoblast International Sarl, Osiris Therapeutics, Inc.. Active years: 2013-2023.
Company Filing History:
Years Active: 2013-2023
Title: Diane Carter: Innovator in Stem Cell Research
Introduction
Diane Carter is a prominent inventor based in Huntington, MD (US). She has made significant contributions to the field of stem cell research, holding a total of 2 patents. Her work focuses on the therapeutic applications of mesenchymal stem cells, particularly in the treatment of graft-versus-host disease.
Latest Patents
Diane's latest patents include innovative methods involving mesenchymal stem cells expressing TNF-α receptors. The first patent describes mesenchymal stem cells that express TNF-α receptor Type I in an amount of at least 13 pg/10 cells. These cells have the ability to inhibit the proliferation of lymphocytes, making them valuable in treating graft-versus-host disease. The second patent reiterates similar findings, emphasizing the potential of these mesenchymal stem cells in therapeutic applications.
Career Highlights
Throughout her career, Diane has worked with notable companies in the biotechnology sector. She has been associated with Osiris Therapeutics, Inc. and Mesoblast International Sàrl, where she has contributed her expertise in stem cell technology. Her work has been instrumental in advancing the understanding and application of stem cells in medical treatments.
Collaborations
Diane has collaborated with esteemed colleagues in her field, including Alla Danilkovitch and Simon Bubnic. These collaborations have further enriched her research and have led to significant advancements in stem cell therapies.
Conclusion
Diane Carter's innovative work in stem cell research has positioned her as a key figure in the field. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.